期刊文献+

去乙酰化酶6在胃癌中的表达及其临床意义

Expression and Clinical Significance of Histone Deacetylase 6 in Gastric Cancer
原文传递
导出
摘要 目的探讨去乙酰化酶6在胃癌中的表达及其临床意义。方法选取作者医院2011-10/2013-10月收治的胃癌患者87例为观察组,选取本院同期胃黏膜慢性炎症患者83例为对照组,采用免疫组织化学和原位杂交法检测去乙酰化酶6蛋白和mRNA的表达,分析胃癌患者病理组织的分化程度、浸润深度、淋巴结转移与乙酰化酶6蛋白和mRNA表达的关系,分析胃癌患者乙酰化酶6蛋白与mRNA的相关性。结果观察组患者乙酰化酶6蛋白阳性率、乙酰化酶6 mRNA阳性率均明显高于对照组。乙酰化酶6蛋白、乙酰化酶6 mRNA与病理组织分化程度、病理组织浸润深度、淋巴结转移均具有明显的正相关性。结论乙酰化酶6蛋白和mRNA表达有助于判定胃癌患者的临床病症和生物学行为,具有高度的临床意义。 Objective To investigate expression and clinical significance of histone deacetylase 6 in gastric cancer. Methods A total of 87 patients with gastric cancer were selected in hospital from October 2011 to October 2013 as obser vation group. Another 83 patients with chronic inflammation of gastric mucosa were selected at the same period as control group. Histone deacetylase 6 protein and mRNA were detected by imrnunohistochemistry and in situ hybridization. Rela tionship between histone deacetylase 6 protein, mRNA and degree of histologic differentiation, invasion depth, and lymph node metastasis were analyzed. Relevance of histone deacetylase 6 protein and mRNA were analyzed. Results Positive rates of histone deacetylase 6 protein and mRNA in observation group were obviously higher than control group. Histone deacetylase 6 protein, and mRNA had obvious positive correlation with degree of histologic differentiation, invasion depth and lymph node metastasis. Histone deacetylase 6 protein had obvious positive correlation with mRNA.Conclusion His- tone deacetylase 6 protein and mRNA is helpful in identifying clinical symptoms and biological behavior, which has clini cal significance.
出处 《华南国防医学杂志》 CAS 2014年第9期866-868,共3页 Military Medical Journal of South China
基金 深圳市龙岗区科技项目(YS2013094)
关键词 去乙酰化酶6 胃癌 MRNA Histone deacetylase 6 Gastric cancer MRNA
  • 相关文献

参考文献11

  • 1Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical[J]. Semin Cancer Biol, 2013,23 (6) : 492-501.
  • 2Pinho SS, Carvalho S, Marcos Pinto R, et al. Gastric cancer: adding glycosylation to the equation[J]. Trends Mol Med, 2013, 19(11 ) : 664-676.
  • 3Zhuang Y, Nguyen HT, Lasky JA,et a/.Requirement of a novel splicing variant of human histone deacetylase 6 for TGF- beta1 mediated gene activation [J]. Biochem Biophys Res Commun, 2010, 392(4): 608-613.
  • 4Kim IA, No M, Lee JM,et al.Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: Potential role of histone deacetylase 6[J]. Radiother Oncol, 2009,92(1) : 125-132.
  • 5Husain M, Harrod KS. Influenza A virus-induced caspase 3 cleaves the histone deaeetylase 6 in infected epithelial cells[J ]. FEBS Lett, 2(109,583(15): 2517-2520.
  • 6Faria GR, Pinto-deSousa J, Preto JR, et al. Three decades of clinical-pathological trends in gastric cancer: prospective data from a portuguese hospital[J]. Int J Surg, 2013,11 (6): 472- 476.
  • 7Lansdorp-Vogelaar I, Sharp L.Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention[J]. Best Pract Res Clin Gastroenterol, 2013, 27(6): 933-947.
  • 8华方方,夏永华,陈瑞香,王玉红,潘莹,杨君,梁武风.组蛋白去乙酰化酶6在宫颈癌组织中的表达及其临床意义[J].中国病理生理杂志,2012,28(8):1507-1509. 被引量:3
  • 9李斌,王济明.组蛋白去乙酰化酶6(HDAC6)与肿瘤[J].临床和实验医学杂志,2006,5(12):2030-2031. 被引量:3
  • 10张文靖,杨建萍,李晟磊.组蛋白去乙酰化酶6在胃癌组织中的表达及意义[J].广东医学,2012,33(2):223-226. 被引量:5

二级参考文献55

  • 1李晟磊,赵秋民,刘宗文,赵志华,高冬玲,郑湘予,陈奎生,张云汉.食管鳞癌中RECK和MMP-9蛋白表达的相关性及临床病理意义[J].世界华人消化杂志,2007,15(10):1082-1086. 被引量:34
  • 2VERDIN E,DEQUIEDT F,KASLER H G.ClassⅡhistone deacetylases:versatile regulators[J].Trends Genet,2003,19(5):286-293.
  • 3SAKUMA T,UZAWA K,ONDA T,et al.Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma[J].Int J Oncol,2006,29(1):117-124.
  • 4ARTS J,ANGIBAUD P,MARIЁN A,et al.R306465 is a novel potent inhibitor of class Ⅰ histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies[J].Br J Cancer,2007,97(10):1344-1353.
  • 5MARKS P A,MILLER T,RICHON V M.Histone deacetylases[J].Curr Opin Pharmacol,2003,3(4):344-351.
  • 6MARCUS A I,ZHOU J,O′BRATE A,et al.The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclita xel enhances tubulin acetylation and requires a functional tubulin deacetylase[J].Cancer Res,2005,65(9):3883-3893.
  • 7SAJI S,KAWAKAMI M,HAYASHI S,et al.Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer[J].Oncogene,2005,24(28):4531-4539.
  • 8CAREW J S,GILES F J,NAWROCKI S T.Histone deacetylase inhibitors:mechanisms of cell death and promise in combination cancer therapy[J].Cancer Lett,2008,269(1):7-17.
  • 9WU Y,SONG S W,SUN J,et al.IIp45 inhibits cell migration through inhibition of HDAC6[J].J Biol Chem,2010,285(6):3554-3560.
  • 10SUZUKI J,CHEN Y Y,SCOTT G K,et al.Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression[J].Clin Cancer Res,2009,15(9):3163-3171.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部